“…Geleophysic dysplasia (GPHYSD1, MIM231050; GPHYSD2, MIM614185; GPHYSD3, MIM617809) is a connective tissue disorder presenting with short stature, small hands and feet, cardiac valvular disease, hepatomegaly, joint contractures, and thickened skin (Rosser, Wilkinson, Hurst, McGaughran, & Donnai, ; Spranger, Gilbert, Tuffli, Rossiter, & Opitz, ; Vanace, Friedman, & Wagner, ). Although initially suspected to be a lysosomal storage disorder (Lipson, Kan, & Kozlowski, ; Wraith, Bankier, Chow, Danks, & Sardharwalla, ), GPHYSD was later recognized to be caused by mutations in genes encoding components of the extracellular matrix (ECM) including a disintegrin and metalloproteinase with thrombospondin motifs like 2 (ADAMTSL2, MIM612277) (GPHYSD1) (Le Goff et al, ), fibrillin 1 ( FBN1 , MIM134797) (GPHYSD2) (Le Goff et al, ), and latent transforming growth factor β (TGF‐β) binding protein 3 ( LTBP3 , MIM 602090) (GPHYSD3) (McInerney‐Leo et al, ). Transforming Growth Factor‐β (TGF‐β) is sequestered in an inactive and latent form by interactions with several ECM proteins and ordered polymers of fibrillin bind latent TGF‐β maintaining TFG‐β biologically inactive.…”